Health Maintenance in Inflammatory Bowel Disease
Purpose of Review
Patients with inflammatory bowel disease (IBD) are not receiving preventative care services at the same rate as the general population. IBD patients are at increased risk for infections, osteoporosis, and certain malignancies secondary to their disease and as they are on immunosuppressive therapy. They are a younger population and often times consider their gastroenterologist as their primary care physician. In this review, we discuss up-to-date evidence pertaining to vaccine-preventable illnesses in the immunosuppressed IBD patient, screening for bone health, cervical cancer, skin malignancies, psychological wellbeing, and smoking cessation.
Vaccinations are recommended in the IBD population as they are immunosuppressed and at increased risk for acquiring influenza and pneumonia. Not only are they at greater risk to acquire it but they also have a much severe complicated course. Ideally, IBD patients should be vaccinated prior to initiating immunosuppression and most inactive vaccines can be administered to them while they are on therapy. All IBD patients should be encouraged to stop smoking and have adequate vitamin D intake along with appropriate applicable cancer screenings.
Gastroenterologists must work in collaboration with primary care providers along with other specialists to help provide our patients well-rounded care for their IBD.
KeywordsHealth maintenance in inflammatory bowel disease Preventative care Vaccinations Bone health Skin cancer
Compliance with Ethical Guidelines
Conflict of Interest
Sunanda Kane reports working as a consultant to AbbVie, Janssen, and Seres and received research funding from UCB. Fazia Mir declares no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 1.Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 2017;152(2):313–321 e2.Google Scholar
- 2.• Selby L, Kane S, Wilson J, Balla P, Riff B, Bingcang C, et al. Receipt of preventive health services by IBD patients is significantly lower than by primary care patients. Inflamm Bowel Dis. 2008; 14(2):253–8. The first article published before the widespread use of biologics for IBD to address an issue that had not been recognized previously. Google Scholar
- 5.Reich J, Wasan S, Farraye FA. Vaccinating patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2016; 12(9):540–546.Google Scholar
- 11.• Long MD, Gulati A, Wohl D, Herfarth H. Immunizations in pediatric and adult patients with inflammatory bowel disease: a practical case-based approach. Inflamm Bowel Dis. 2015;21(8):1993–2003. A practical clinically relevant article that can help clinicians at the bedside decide what vaccines are appropriate for their patients CrossRefPubMedGoogle Scholar
- 14.Andrisani G, Frasca D, Romero M, Armuzzi A, Felice C, Marzo M, et al. Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-alpha agents: effects of combined therapy with immunosuppressants. J Crohns Colitis. 2013;7(4):301–7.CrossRefPubMedGoogle Scholar
- 20.Kim DK, Bridges CB, Harriman KH, Advisory Committee on Immunization P. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older: United States, 2016. Ann Intern Med 2016; 164(3):184–194.Google Scholar
- 23.Reich JS, Miller HL, Wasan SK, Noronha A, Ardagna E, Sullivan K, et al. Influenza and pneumococcal vaccination rates in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2015;11(6):396–401.Google Scholar
- 26.• Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG Clinical Guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017; 112(2):241–58. An up-to-date evidence-based guideline for all of the issues mentioned in this article. Google Scholar
- 29.Bernstein CN. Osteoporosis in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006; 4(2):152–156.Google Scholar
- 58.Sifuentes H, Kane S. Monitoring for extra-intestinal cancers in IBD. Curr Gastroenterol Rep 2015; 17 (11):42.Google Scholar
- 61.Reasons Reported by Medicare Beneficiaries for Not Receiving Influenza and Pneumococcal Vaccinations -- United States, 1996. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm4839a4.htm. Accessed 2 Oct, 2017.
- 62.Pneumococcal Vaccine Recommendations | Vaccines and Immunizations | CDC. https://www.cdc.gov/vaccines/vpd/pneumo/hcp/recommendations.html. Accessed 2 Oct 2017.
- 63.ACIP Pneumococcal Vaccine Recommendations | CDC. https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html. Accessed 2 Oct 2017.